{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:34:11Z","timestamp":1758357251781,"version":"3.44.0"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.2169\/internalmedicine.4597-24","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:12:02Z","timestamp":1742580722000},"page":"2728-2732","source":"Crossref","is-referenced-by-count":0,"title":["Development of Graves' Disease after Resection of an Autonomously Functioning Thyroid Nodule"],"prefix":"10.2169","volume":"64","author":[{"given":"Shigenori","family":"Nakamura","sequence":"first","affiliation":[{"name":"Thyroid and Diabetic Division, Department of Internal Medicine, Japanese Red Cross Gifu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nishikawa M, Yoshimura M, Yoshikawa N, et al. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome. Endocr J 44: 571-574, 1997.","DOI":"10.1507\/endocrj.44.571"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Danno H, Nishihara E, Kousaka K, et al. Prevalence and treatment outcomes of Marine-Lenhart Syndrome in Japan. Eur Thyroid J 10: 461-467, 2021.","DOI":"10.1159\/000510312"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ikekubo K, Hino M, Ito H, et al. The development of a solitary toxic thyroid nodule following Graves' disease. Clin Nucl Med 13: 748-750, 1988.","DOI":"10.1097\/00003072-198810000-00014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Giuffrida G, Giovinazzo S, Certo R, et al. An uncommon case of Marine-Lenhart syndrome. Arq Bras Endocrinol Metabol 58: 398-401, 2014.","DOI":"10.1590\/0004-2730000003173"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rosenfeld PS, Burgos-Vasquez F. Development of Graves' disease in a patient with an autonomous thyroid nodule. South Med J 63: 549-551, 1970.","DOI":"10.1097\/00007611-197005000-00015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bendezu R, Wieland RG, Tang P, Levine B. Unusual events preceding hyperthyroidism with diffuse goiter. Arch Intern Med 137: 1023-1025, 1977.","DOI":"10.1001\/archinte.1977.03630200031011"},{"key":"7","unstructured":"7. Freeman JS, Ertel NH, McA'Nulty JA, Khan MY. Graves' disease following resection of an autonomous solitary thyroid adenoma. J Med Soc N J 80: 444-446, 1983."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vento JA, Slavin JD Jr, Reardon GE, Spencer RP. Graves' disease. Initial presentation with exophthalmos and solitary hot nodule. Clin Nucl Med 11: 404-406, 1986.","DOI":"10.1097\/00003072-198606000-00008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Smyth PPA, Neylan D, McMullan NM, Smith DF, McKenna TJ. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators. Acta Endocrinol (Copenh) 118: 474-478, 1988.","DOI":"10.1530\/acta.0.1180474"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Monzani F, Del Guerra P, Caraccio N, Casolaro A, Lippolis PV, Goletti O. Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. J Endocrinol Invest 20: 294-298, 1997.","DOI":"10.1007\/BF03350304"},{"key":"11","unstructured":"11. Gallegos E, Meier DA, Garcia M. Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma. J Nucl Med 38: 260-262, 1997."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Verde G. Graves' disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma. J Endocrinol Invest 21: 334-335, 1998.","DOI":"10.1007\/BF03350338"},{"key":"13","unstructured":"13. Orsolon P, Lupi A, De Antoni, Migliorati G, Vianello Dri A. Appearance of Graves'-like disease following regression of autonomously functioning thyroid nodules. Two case reports. Minerva Endocrinol 23: 53-56, 1998."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Le Moli R, Russo M, Malandrino P, Vella V, Belfiore A, Frasca F. Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis. Hormones (Athens) 20: 161-165, 2021.","DOI":"10.1007\/s42000-020-00215-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 78: 393-397, 1994.","DOI":"10.1210\/jcem.78.2.8106628"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343-1421, 2016.","DOI":"10.1089\/thy.2016.0229"},{"key":"17","unstructured":"17. Ross DS. Thionamides in the treatment of Graves' disease. UpToDate [Internet]. [cited 2024 Oct 25]. Available from: https:\/\/www.uptodate.com\/contents\/thionamides-in-the-treatment-of-graves-disease."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128: 51-55, 1993.","DOI":"10.1530\/acta.0.1280051"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 50: 1089-1093, 1980.","DOI":"10.1210\/jcem-50-6-1089"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Belfiore A, Sava L, Runello F, Tomaselli L, Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab 56: 283-287, 1983.","DOI":"10.1210\/jcem-56-2-283"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Eyre-Brook IA, Talbot CH. The treatment of autonomous functioning thyroid nodules. Br J Surg 69: 577-579, 1982.","DOI":"10.1002\/bjs.1800691006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dunkelmann S, Wolf R, Koch A, Kittner C, Groth P, Schuemichen C. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay. Eur J Nucl Med Mol Imaging 31: 1428-1434, 2004.","DOI":"10.1007\/s00259-004-1519-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schmidt M, Gorbauch E, Dietlein M, et al. Incidence of postradioiodine immunogenic hyperthyroidism\/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. Thyroid 16: 281-288, 2006.","DOI":"10.1089\/thy.2006.16.281"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Takasu N, Yamada T, Sato A, et al. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clin Endocrinol (Oxf) 33: 687-698, 1990.","DOI":"10.1111\/j.1365-2265.1990.tb03906.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gonzalez-Aguilera B, Betea D, Lutteri L, et al. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab 62: 609-614, 2018.","DOI":"10.20945\/2359-3997000000086"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Daramjav N, Takagi J, Iwayama H, et al. Autoimmune thyroiditis shifting from Hashimoto's thyroiditis to Graves' disease. Medicina (Kaunas) 59: 757, 2023.","DOI":"10.3390\/medicina59040757"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nygaard B, Knudsen JH, Heged\u00fcs L, Scient AV, Hansen JE. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131<\/sup>I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82: 2926-2930, 1997.","DOI":"10.1210\/jc.82.9.2926"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Nygaard B, Faber J, Veje A, Heged\u00fcs L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid 9: 477-481, 1999.","DOI":"10.1089\/thy.1999.9.477"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jin M, Jang A, Kim WG, et al. Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer. PLoS One 17: e0265332, 2022.","DOI":"10.1371\/journal.pone.0265332"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wan H, Zhang Y, Chen Y. Characterization of Graves' disease development after partial thyroidectomy for thyroid cancer. Transl Cancer Res 10: 3168-3176, 2021.","DOI":"10.21037\/tcr-21-501"},{"key":"31","unstructured":"31. Chao TC. Female sex hormones and the immune system. Changgeng Yi Xue Za Zhi 19: 95-106, 1996."},{"key":"32","unstructured":"32. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121: 531-551, 1985."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4597-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T03:26:55Z","timestamp":1758338815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4597-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4597-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"4597-24"}}